KK, R., MM, G., A, L., AT, T., GM, G., R, S., . . . H, W. (2023). Microembolic signal monitoring in patients with HeartMate 3 and HeartWare left ventricular assist devices: Association with antithrombotic treatment and cerebrovascular events. Artificial organs, 47(2), 370. https://doi.org/10.1111/aor.14409
Chicago Style (17th ed.) CitationKK, Ravenberg, et al. "Microembolic Signal Monitoring in Patients with HeartMate 3 and HeartWare Left Ventricular Assist Devices: Association with Antithrombotic Treatment and Cerebrovascular Events." Artificial Organs 47, no. 2 (2023): 370. https://doi.org/10.1111/aor.14409.
MLA (9th ed.) CitationKK, Ravenberg, et al. "Microembolic Signal Monitoring in Patients with HeartMate 3 and HeartWare Left Ventricular Assist Devices: Association with Antithrombotic Treatment and Cerebrovascular Events." Artificial Organs, vol. 47, no. 2, 2023, p. 370, https://doi.org/10.1111/aor.14409.